Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Strandin

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|July 28, 2023
Complete Protection from SARS-CoV-2 Lung Infection in Mice Through Combined Intranasal Delivery of PIKfyve Kinase and TMPRSS2 Protease InhibitorsRavi Kant, Lauri Kareinen, Ravi Ojha, et al.
Plos Pathogens|March 10, 2021
Monocyte subset redistribution from blood to kidneys in patients with Puumala virus caused hemorrhagic fever with renal syndromeSindhu Vangeti, Tomas Strandin, Sang Liu, et al.
Plos Pathogens|August 25, 2021
Correction: Monocyte subset redistribution from blood to kidneys in patients with Puumala virus caused hemorrhagic fever with renal syndromeSindhu Vangeti, Tomas Strandin, Sang Liu, et al.
ACS Chemical Biology|October 18, 2021
Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural ProductsMuhammad N Ahmed, Matti Wahlsten, Jouni Jokela, et al.
Microbiology Spectrum|February 16, 2024
Nanobody engineering for SARS-CoV-2 neutralization and detectionLiina Hannula, Suvi Kuivanen, Jonathan Lasham, et al.
Virus Research|January 11, 2024
Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patientsXiaobo Huang, Jonas Kantonen, Kirsten Nowlan, et al.
Plos Pathogens|August 22, 2024
The assembly of neutrophil inflammasomes during COVID-19 is mediated by type I interferonsLuz E Cabrera, Suvi T Jokiranta, Sanna Mäki, et al.
Plos Pathogens|July 6, 2021
Characterization of low-density granulocytes in COVID-19Luz E Cabrera, Pirkka T Pekkarinen, Maria Alander, et al.
Emerging Infectious Diseases|May 24, 2022
Experimental Infection of Mink with SARS-COV-2 Omicron Variant and Subsequent Clinical DiseaseJenni Virtanen, Kirsi Aaltonen, Kristel Kegler, et al.
Plos Pathogens|July 22, 2024
Innate lymphoid cells are activated in HFRS, and their function can be modulated by hantavirus-induced type I interferonsMarina García, Anna Carrasco García, Whitney Weigel, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|July 28, 2023
Complete Protection from SARS-CoV-2 Lung Infection in Mice Through Combined Intranasal Delivery of PIKfyve Kinase and TMPRSS2 Protease InhibitorsRavi Kant, Lauri Kareinen, Ravi Ojha, et al.
Plos Pathogens|March 10, 2021
Monocyte subset redistribution from blood to kidneys in patients with Puumala virus caused hemorrhagic fever with renal syndromeSindhu Vangeti, Tomas Strandin, Sang Liu, et al.
Plos Pathogens|August 25, 2021
Correction: Monocyte subset redistribution from blood to kidneys in patients with Puumala virus caused hemorrhagic fever with renal syndromeSindhu Vangeti, Tomas Strandin, Sang Liu, et al.
ACS Chemical Biology|October 18, 2021
Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural ProductsMuhammad N Ahmed, Matti Wahlsten, Jouni Jokela, et al.
Microbiology Spectrum|February 16, 2024
Nanobody engineering for SARS-CoV-2 neutralization and detectionLiina Hannula, Suvi Kuivanen, Jonathan Lasham, et al.
Virus Research|January 11, 2024
Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patientsXiaobo Huang, Jonas Kantonen, Kirsten Nowlan, et al.
Plos Pathogens|August 22, 2024
The assembly of neutrophil inflammasomes during COVID-19 is mediated by type I interferonsLuz E Cabrera, Suvi T Jokiranta, Sanna Mäki, et al.
Plos Pathogens|July 6, 2021
Characterization of low-density granulocytes in COVID-19Luz E Cabrera, Pirkka T Pekkarinen, Maria Alander, et al.
Emerging Infectious Diseases|May 24, 2022
Experimental Infection of Mink with SARS-COV-2 Omicron Variant and Subsequent Clinical DiseaseJenni Virtanen, Kirsi Aaltonen, Kristel Kegler, et al.
Plos Pathogens|July 22, 2024
Innate lymphoid cells are activated in HFRS, and their function can be modulated by hantavirus-induced type I interferonsMarina García, Anna Carrasco García, Whitney Weigel, et al.
Pageof 7